The role of radiolabeled somatostatin analogs in adrenal imaging
- 1 August 1996
- journal article
- clinical trial
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 23 (6) , 677-680
- https://doi.org/10.1016/0969-8051(96)00065-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1995
- The Diagnosis of Nonfunctioning Pheochromocytoma The Role of I-123 MIBG ImagingClinical Nuclear Medicine, 1995
- State-of-the-art MR imaging of the adrenal gland.RadioGraphics, 1994
- Differentiation of adrenal masses with MR imaging: comparison of techniques.Radiology, 1994
- Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993
- Integrated imaging of adrenal disease.Radiology, 1992
- The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of TumorsEndocrine Reviews, 1991
- MR characterization of adrenal masses: field strength and pulse sequence considerations.Radiology, 1989
- Adrenal tissue characterization using MR imaging.Radiology, 1986